231 related articles for article (PubMed ID: 10226901)
1. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
[TBL] [Abstract][Full Text] [Related]
2. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
[TBL] [Abstract][Full Text] [Related]
4. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandin E1 infusion in severe chronic heart failure.
Pacher R; Stanek B; Hülsmann M; Sinzinger H
Prostaglandins; 1997 Apr; 53(4):221-35. PubMed ID: 9167210
[TBL] [Abstract][Full Text] [Related]
6. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
10. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
[TBL] [Abstract][Full Text] [Related]
11. A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure after cardiac surgery.
Kieler-Jensen N; Houltz E; Ricksten SE
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):641-6. PubMed ID: 8664453
[TBL] [Abstract][Full Text] [Related]
12. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
[TBL] [Abstract][Full Text] [Related]
13. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
[TBL] [Abstract][Full Text] [Related]
14. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
15. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.
Serra W; Musiari L; Ardissino D; Gherli T; Montanari A
Int J Cardiol; 2011 Jan; 146(1):e10-5. PubMed ID: 19176262
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).
Califf RM; Adams KF; McKenna WJ; Gheorghiade M; Uretsky BF; McNulty SE; Darius H; Schulman K; Zannad F; Handberg-Thurmond E; Harrell FE; Wheeler W; Soler-Soler J; Swedberg K
Am Heart J; 1997 Jul; 134(1):44-54. PubMed ID: 9266782
[TBL] [Abstract][Full Text] [Related]
17. [Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure].
Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E
Wien Klin Wochenschr; 1996; 108(16):505-9. PubMed ID: 8967094
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
19. Dose-effect relationships of prostaglandin E1 in severe endstage chronic heart failure.
Stanek B; Pacher R
Jpn Heart J; 1997 Jan; 38(1):53-65. PubMed ID: 9186281
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group.
Sueta CA; Gheorghiade M; Adams KF; Bourge RC; Murali S; Uretsky BF; Pritzker MR; McGoon MD; Butman SM; Grossman SH
Am J Cardiol; 1995 Jan; 75(3):34A-43A. PubMed ID: 7840053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
